David S. Weinberg, MD, MSc, Appointed to the Audrey Weg Schaus and Geoffrey Alan Weg Endowed Chair in Medical Science

PHILADELPHIA (June 28, 2011) — David S. Weinberg, MD, MSc, Chair of the Department of Medicine and Director of Gastroenterology at Fox Chase Cancer Center, has been appointed to the Audrey Weg Schaus and Geoffrey Alan Weg Endowed Chair in Medical Science. Fox Chase's 16 endowed chairs, each supported by generous philanthropists, allow the institution to recognize outstanding clinicians and researchers and ensure funding for promising lines of research.

"I am deeply honored by this appointment and thankful to the Weg family for their profound generosity in funding this chair," Weinberg says. "As a researcher who also maintains an active clinical practice, I see firsthand how research advances can have a positive impact on patients. The financial support provided by the endowed chairs, furnished by magnanimous people like the Wegs, is vital to ensuring that this critical research continues."

The Audrey Weg Schaus and Geoffrey Alan Weg Chair in Medical Science recognizes and supports an outstanding leader in medical science who represents the highest standards of excellence. The chair was established in 2001 by Fox Chase Board of Directors member Kenneth E. Weg and his wife Carol Weg, and is named for their children.

"This appointment is a wonderful way to both recognize Dr. Weinberg's outstanding work at the Center over the last decade and support him as he continues to conduct crucial research," says Michael V. Seiden, MD, PhD, President and CEO of Fox Chase. "Because his research focuses heavily on prevention and screening, Dr. Weinberg is a natural choice for this chair, which Carol and Kenneth Weg named for their children to underscore its focus on benefitting future generations."

In addition to operating an active clinical practice in general gastroenterology, Dr. Weinberg is a distinguished cancer researcher. His work focuses primarily on the prevention and control of gastrointestinal malignancies with a particular interest in novel methods to promote cancer screening utilization and the role of novel biomarkers in cancer prevention and control.

Prior to joining Fox Chase in 2001, Weinberg received his undergraduate degree from Yale University, earned his MD from Cornell University Medical College, and completed an internship and residency in internal medicine at Beth Israel Hospital in Boston and Gastroenterology fellowship training at the University of Pennsylvania. Recently, he was named a "Top Doctor" in the May issue of Philadelphia magazine.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427